[Market Focus] Aptamer Sciences Hits Upper Price Limit on News of Aribio Acquisition Attempt
Aptamer Sciences hit the upper price limit in early trading on July 3. The news that Aribio is seeking to acquire the company appears to have sparked investor interest.
As of 9:26 a.m. on this day, Aptamer Sciences shares were up by the daily maximum of 29.99% on the KOSDAQ market, trading at 1,634 won. The stock immediately reached the upper price limit as soon as the market opened.
Hot Picks Today
"Common in Korea, but One Drop at the End... The Global Craze for the 'Taste of Korea'"
- "Target Price Raised from 650,000 to 1,850,000 Won" Semiconductor Substrate Latecomer Rapidly Narrows Technology Gap [Click e-Stock]
- Blooming for Just One Night After Years of Waiting... 'Queen of the Night' Cactus Video Released
- "I Secretly Made 100 Million Won from Stocks Without My Wife Knowing. How Can I Tell Her Without Getting in Trouble?"... Husband's Dilemma Sparks Buzz
- “Tank, Your Drink Is Ready”: Starbucks Becomes a Playground for Hate... May 18 Groups Demand Action
On this day, it was reported that Aribio, a company developing treatments for dementia, recently expressed its intention to acquire Aptamer Sciences. Aribio had previously attempted to enter the KOSDAQ market through a technology-based special listing but failed multiple times. As a result, there is speculation that Aribio is pursuing the acquisition of Aptamer Sciences as a means of backdoor listing. Aptamer Sciences was listed on the KOSDAQ market in September 2020.
![[Market Focus] Aptamer Sciences Hits Upper Price Limit on News of Aribio Acquisition Attempt](http://www.asiae.co.kr/news/img_view.htm?img=2025070209292929984_1751416169.jpg)
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
